UBS AM’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.7M Buy
783,995
+533,664
+213% +$54.8M 0.01% 571
2025
Q4
$23.8M Buy
+250,331
New +$25.2M 0.01% 798
2025
Q3
Sell
-256,874
Closed -$27.3M 2327
2025
Q2
$27.3M Buy
256,874
+38,452
+18% +$3.88M 0.01% 923
2025
Q1
$19.9M Sell
218,422
-2,658
-1% -$298K 0.01% 969
2024
Q4
$25.2M Buy
221,080
+36,746
+20% +$4.19M 0.01% 863
2024
Q3
$21.9M Sell
184,334
-47,213
-20% -$4.34M 0.01% 908
2024
Q2
$18.6M Buy
231,547
+17,558
+8% +$1.6M 0.01% 889
2024
Q1
$19.7M Sell
213,989
-781,264
-78% -$74.9M 0.01% 796
2023
Q4
$105M Buy
995,253
+137,115
+16% +$13.8M 0.04% 421
2023
Q3
$93.2M Buy
858,138
+397,315
+86% +$43.9M 0.04% 417
2023
Q2
$57.4M Hold
460,823
0.03% 523
2023
Q1
$57.4M Sell
460,823
-19,478
-4% -$2.67M 0.03% 523
2022
Q4
$72.2M Buy
480,301
+140,865
+41% +$21.7M 0.04% 461
2022
Q3
$45.8M Buy
339,436
+134,663
+66% +$20.6M 0.03% 574
2022
Q2
$30.5M Buy
204,773
+24,700
+14% +$3.77M 0.02% 648
2022
Q1
$30.7M Buy
180,073
+28,446
+19% +$4.78M 0.01% 730
2021
Q4
$39.1M Buy
151,627
+58,400
+63% +$16M 0.02% 716
2021
Q3
$25.5M Sell
93,227
-33,271
-26% -$10.6M 0.01% 810
2021
Q2
$28.3M Sell
126,498
-201,340
-61% -$38M 0.01% 795
2021
Q1
$35.8M Buy
327,838
+46,556
+17% +$4.94M 0.02% 705
2020
Q4
$22.9M Buy
281,282
+141,090
+101% +$13.9M 0.01% 818
2020
Q3
$9.71M Sell
140,192
-62,014
-31% -$4.45M 0.01% 950
2020
Q2
$13.5M Buy
+202,206
New +$10.1M 0.01% 841

Other funds holding BNTX